Answers are grounded in this paper and cite their sources.
Affinity purification assays identify peptide inhibitors affecting ribosome biogenesis in cancer cells, highlighting therapeutic potential.
Programmed cell death 2 (PDCD2) is an evolutionarily conserved protein essential for cell viability from yeast to humans.PDCD2 functions as a dedicated chaperone to the 40S ribosomal protein uS5 and loss of PDCD2 function impairs ribosome biogenesis.As cancer cells require a substantial supply of ribosomes to maintain elevated levels of protein synthesis, targeting the protein interaction interface between PDCD2 and uS5 is a promising modality to mitigate ribosome biogenesis.In this study, we used affinity purification assays and structural modeling to identify a stretch of 30 amino acids in the N-terminal region of uS5 that is necessary and sufficient for interaction with PDCD2.Our data also identified a conserved FxxGFG motif in uS5 that is important for association with PDCD2 via hydrophobic interactions.Notably, we developed a sensitive complementation-based biosensor that can monitor PDCD2-uS5 interaction in cell extracts and living human cells.Using this biosensor, we identified a 11-amino acid uS5-derived peptide that inhibits the PDCD2-uS5 interaction and impairs cancer cell viability.Such peptides provide a starting point in the development of peptidomimetic inhibitors capable of modulating ribosome biogenesis via disruption of ribosomal protein-dedicated chaperone complexes.
No takes yet. Share an insight, caveat, or question.
Hassani et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: